Skip to content

Confirmation of calcium absorption promoting action in mannooligosaccharides

Confirmation of calcium absorption promoting action in mannooligosaccharides - Confirmation of calcium absorption promoting action in mannooligosaccharides

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046111
Enrollment
30
Registered
2022-12-01
Start date
2021-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test drink 1 once a day for 1week Intake of test drink 2 once a day for 1week Intake of placebo drink once a day for 1week

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1)Healthy female aged 20-70 years (2)Subjects who have received a sufficient explanation of the purpose and contents of the examination, have the ability to consent, have well understood, volunteered to participate, and have signed the informed consent document

Exclusion criteria

Exclusion criteria: (1)Subjects who affected from chronic illness and are taking drugs (2)Subjects who have bone-related diseases (3)Subjects who have a medical history of diseases such as malignant tumor, heart failure, myocardial infarction, arrhythmia, liver dysfunction, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, urinary stones, etc. (4)Subjects who are taiking supplements (including foods for specified health use and foods with functional claims) (5)Subjects who regularly drink milk (6)Subjects working in night shifts (7)Subjects who who always have diarrhea (8)Subjects who have a history of gastrointestinal disorders and gastrointestinal surgery that affect gastrointestinal absorption (9)Subjects who have allergies to food ingredients contained in test foods (10)Subjects who are pregnant, breastfeeding, or willing to become pregnant (11)Subjects who have collected more than 200 mL of blood within 12 weeks prior to the screening test (12)Subjects who participate in other clinical trials (food, pharmaceuticals and cosmetics), who have participated in other tests within one month of obtaining consent, or who are willing to participate (13)Subjects who are judged as unsuitable for the study by the investigators

Design outcomes

Primary

MeasureTime frame
Excreted urinary calcium

Secondary

MeasureTime frame
Urinary deoxypyridinoline Urinary NTx

Countries

Japan

Contacts

Public ContactToshio Kumao

Ajinomoto AGF, INC. Technology Development Dept. Technical Research and Development Institute

toshio.kumaoh.hv8@agf.co.jp080-3721-4520

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026